Seeking Alpha

Revolution Medicines: Early-Stage Firm Whose High Valuation I Cannot Explain

Revolution Medicines, Inc. is undoubtedly doing interesting science. However, I can name 10 companies that are doing equally interesting science but are valued at a fifth of Revolution Medicines stock ...
The Globe and Mail

BeOne Medicines Advances Early Cancer Trial for BG-75098, Signaling Steady Pipeline Progress

BeOne Medicines is running an early-stage trial to test a new cancer drug, BG-75098, in adults with advanced solid tumors. The official title shows a Phase 1a/1b open-label study that aims to assess ...
JSTOR Daily

Early Patient Access to Medicines: Health Technology Assessment Bodies Need to Catch Up with New Marketing Authorization Methods

Public Health Genomics, Vol. 19, No. 3, Access for All: A Personalised Approach (2016), pp. 187-191 (5 pages) National and international medicines agencies have developed innovative methods to ...
Seeking Alpha

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

Paris and Cambridge, MA. June 2, 2025. Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare ...
KTLA

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

PARIS and CAMBRIDGE, Mass., June 2, 2025 /PRNewswire/ -- Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic ...